ANTIATHEROSCLEROTIC EFFECTS OF NICARDIPINE AND NIFEDIPINE IN CHOLESTEROL-FED RABBITS

被引：141

作者：

WILLIS, AL

NAGEL, B

CHURCHILL, V

WHYTE, MA

SMITH, DL

MAHMUD, I

PUPPIONE, DL

机构：

来源：

ARTERIOSCLEROSIS | 1985年 / 5卷 / 03期

关键词：

D O I：

10.1161/01.ATV.5.3.250

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：250 / 255

页数：6

共 15 条

[1] SUPPRESSION OF CALCIFIC FIBROUS-FATTY PLAQUE-FORMATION IN RABBITS BY AGENTS NOT AFFECTING ELEVATED SERUM-CHOLESTEROL LEVELS - EFFECT OF THIOPHENE COMPOUNDS [J].

CHAN, CT ;

WELLS, H ;

KRAMSCH, DM .

CIRCULATION RESEARCH, 1978, 43 (01) :115-125

[2]

GINSBURG R, 1983, LAB INVEST, V49, P154

[3] SUPPRESSION OF ATHEROGENESIS IN CHOLESTEROL-FED RABBIT TREATED WITH NIFEDIPINE [J].

HENRY, PD ;

BENTLEY, KI .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1366-1369

[4] COMPARATIVE PHARMACOLOGY OF CALCIUM ANTAGONISTS - NIFEDIPINE, VERAPAMIL AND DILTIAZEM [J].

HENRY, PD .

AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (06) :1047-1058

[5] EFFECTS OF ANTI-CALCIFYING AND ANTI-FIBROBROTIC DRUGS ON PRE-ESTABLISHED ATHEROSCLEROSIS IN THE RABBIT [J].

HOLLANDER, W ;

PADDOCK, J ;

NAGRAJ, S ;

COLOMBO, M ;

KIRKPATRICK, B .

ATHEROSCLEROSIS, 1979, 33 (01) :111-123

[6] ATHEROSCLEROSIS - PREVENTION BY AGENTS NOT AFFECTING ABNORMAL LEVELS OF BLOOD-LIPIDS [J].

KRAMSCH, DM ;

ASPEN, AJ ;

ROZLER, LJ .

SCIENCE, 1981, 213 (4515) :1511-1512

[7] SUPPRESSION OF EXPERIMENTAL ATHEROSCLEROSIS BY THE CA++-ANTAGONIST LANTHANUM - POSSIBLE ROLE OF CALCIUM IN ATHEROGENESIS [J].

KRAMSCH, DM ;

ASPEN, AJ ;

APSTEIN, CS .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (05) :967-981

[8] EFFECT OF AGENTS INTERFERING WITH SOFT-TISSUE CALCIFICATION AND CELL-PROLIFERATION ON CALCIFIC FIBROUS FATTY PLAQUES IN RABBITS [J].

KRAMSCH, DM ;

CHAN, CT .

CIRCULATION RESEARCH, 1978, 42 (04) :562-571

[9]

KRAMSCH DM, 1982, FED PROC, V41, P709

[10] LOW-DENSITY LIPOPROTEIN-LOWERING AND HIGH-DENSITY LIPOPROTEIN-ELEVATING EFFECTS OF NICARDIPINE IN RATS [J].

OHATA, I ;

SAKAMOTO, N ;

NAGANO, K ;

MAENO, H .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (14) :2199-2205

← 1 2 →